CIVALLERO, Monica
 Distribuzione geografica
Continente #
NA - Nord America 3.268
EU - Europa 1.280
AS - Asia 1.146
SA - Sud America 182
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 5.919
Nazione #
US - Stati Uniti d'America 3.239
GB - Regno Unito 427
CN - Cina 396
SG - Singapore 329
IT - Italia 240
HK - Hong Kong 165
SE - Svezia 153
BR - Brasile 141
DE - Germania 119
RU - Federazione Russa 84
VN - Vietnam 83
UA - Ucraina 59
TR - Turchia 47
FR - Francia 39
FI - Finlandia 33
IE - Irlanda 27
BG - Bulgaria 24
ID - Indonesia 22
IN - India 22
KR - Corea 21
MA - Marocco 19
BE - Belgio 18
JP - Giappone 18
CA - Canada 17
AR - Argentina 15
NL - Olanda 15
MX - Messico 10
ZA - Sudafrica 10
MY - Malesia 7
AT - Austria 6
BD - Bangladesh 6
EC - Ecuador 6
LT - Lituania 6
PE - Perù 6
CH - Svizzera 5
CL - Cile 5
EG - Egitto 5
IQ - Iraq 4
PL - Polonia 4
ES - Italia 3
IR - Iran 3
LB - Libano 3
PY - Paraguay 3
RO - Romania 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AU - Australia 2
CZ - Repubblica Ceca 2
IL - Israele 2
KW - Kuwait 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
SY - Repubblica araba siriana 2
AD - Andorra 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CD - Congo 1
CM - Camerun 1
CO - Colombia 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MK - Macedonia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PK - Pakistan 1
QA - Qatar 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.919
Città #
Ashburn 382
Fairfield 375
Santa Clara 335
Southend 304
Chandler 259
Woodbridge 236
Singapore 229
Hong Kong 164
Houston 160
Ann Arbor 130
Seattle 120
Cambridge 117
Nyköping 109
Wilmington 104
Jacksonville 83
Hefei 82
Dearborn 78
London 78
Beijing 64
Modena 57
New York 45
San Diego 39
Los Angeles 37
The Dalles 36
Chicago 28
Dublin 27
Izmir 27
Ho Chi Minh City 26
Frankfurt am Main 25
Princeton 25
Sofia 24
Moscow 23
Fremont 22
Munich 22
Hanoi 21
Seoul 21
Jakarta 20
Shanghai 20
Dallas 19
Eugene 19
Brussels 18
Council Bluffs 17
Salt Lake City 17
Casablanca 16
Cologno Monzese 16
Helsinki 15
Milan 15
São Paulo 14
Norwalk 12
Tokyo 11
Buffalo 10
Des Moines 10
Pisa 10
San Giuliano Milanese 9
Bremen 8
Columbus 8
Falls Church 8
Lviv 8
Brusaporto 7
Nuremberg 7
Parma 7
Redondo Beach 7
Amsterdam 6
Changsha 6
Dong Ket 6
Guangzhou 6
Johannesburg 6
Montreal 6
Phoenix 6
Redwood City 6
Atlanta 5
Boardman 5
Brasília 5
Contagem 5
Latina 5
Ottawa 5
Rome 5
San Francisco 5
Belo Horizonte 4
Bologna 4
Boston 4
Brooklyn 4
Campinas 4
Chongqing 4
Da Nang 4
Nanjing 4
Nova Milanese 4
Orem 4
Poplar 4
Rio de Janeiro 4
Stockholm 4
Toronto 4
Wuhan 4
Arezzo 3
Ascoli Piceno 3
Buenos Aires 3
Curitiba 3
Denver 3
Elk Grove Village 3
Grafing 3
Totale 4.411
Nome #
Cell-penetrating CaCO3nanocrystals for improved transport of NVP-BEZ235 across membrane barrier in T-cell lymphoma 350
Activity of BKM120 and BEZ235 against lymphoma cells 326
Combination of low doses of Enzastaurin and Lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines 313
The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines 310
Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine 299
Calcium-Carbonate Nanocapsules Improve the Efficacy of BEZ235 in Lymphoma a Cell Line: A Promising New Technology of Drug Delivery 284
Rational combinations of enzastaurin with novel targeted agents for patients with B-cell non-Hodgkin's lymphoma 255
NVP-BEZ235 alone and in combination in mantle cell lymphoma: an effective therapeutic strategy 254
Ruxolitinib combined with vorinostat suppresses tumor growth and alters metabolic phenotype in hematological diseases 246
Genomic profiling of enzastaurin-treated B cell lymphoma RL cells 240
Biological effects of Atra and Arsenic Trioxide on short term cultures of non-M3 leukemic blasts 240
Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines. 237
The combination of bortezomib with enzastaurin or lenalidomide enhances cytotoxicity in follicular and mantle cell lymphoma cell lines 236
Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy 220
Effects of Enzastaurin, Alone or in Combination, on Signalling Pathway Controlling Growth and Survival of B-Cell Lymphoma Cell LinesBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 4978 213
The Oral PKC-ß Inhibitor Enzastaurin (LY317615) Suppress Phosphorylation and Induces Apoptosis in Multiple Myeloma Cell Lines by Inhibition of AKT Pathway. 210
Molecular targeting of the PKC-β inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression 202
Citarinostat and Momelotinib co-target HDAC6 and JAK2/STAT3 in lymphoid malignant cell lines: a potential new therapeutic combination 186
ALK-negative anaplastic large cell lymphoma: Features and outcomes of 235 patients from the International T-Cell Project 172
Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project 169
COVID-related disruption in mammographic screening: a year later. 148
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project 148
Survival outcomes for extranodal natural-killer T-cell lymphoma – Authors' reply 145
Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas 142
The Value and relevance of T-cell lymphoma registries 119
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project 108
The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network 103
Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell Project 92
Totale 5.967
Categoria #
all - tutte 24.380
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.380


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021367 0 0 0 0 0 45 40 79 31 83 51 38
2021/2022555 36 29 63 29 9 64 36 22 44 46 107 70
2022/2023648 74 114 44 66 43 95 7 57 88 7 25 28
2023/2024421 18 24 18 50 82 34 43 47 5 17 48 35
2024/20251.230 50 11 36 103 233 179 96 68 120 43 102 189
2025/20261.034 176 84 165 227 323 59 0 0 0 0 0 0
Totale 5.967